Cutaneous peripheral T-cell lymphoma associated with a proliferation of B cells

American Journal of Clinical Pathology

Volumn 131, Issue 6, 2009, Pages 810-819

  Mattoch, Ingerlisa W ^a   Fulton, Regan ^b   Kim, Youn ^b   Hoppe, Richard ^c   Warnke, Roger A ^a   Sundram, Uma N ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

B cells; B cell lymphoma; Cutaneous; Epstein barr virus; Peripheral T cell lymphoma

Indexed keywords

T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MALE; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; FEMALE; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SKIN NEOPLASMS;

EID: 67149136368     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCP5W0VOCSVOBRA     Document Type: Article

References (32)

1. Cerroni L. Lymphoproliferative lesions of the skin. J Clin Pathol. 2006;59:813-826. (Pubitemid 44211742)
2. Norton AJ. Classification of cutaneous lymphoma: a critical appraisal of recent proposals. Am J Dermatopathol. 1999;21:279-287. (Pubitemid 29256826)
3. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785. (Pubitemid 40656118)
4. Slater DN. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants. Br J Dermatol. 2005;153:874-880. (Pubitemid 41540749)
5. Ralfkiaer E, Willemze R, Meijer CJLM, et al. Primary cutaneous peripheral T-cell lymphoma, unspecified. In: LeBoit PE, Burg G, Weedon D, et al, eds. Pathology and Genetics of Skin Tumours. Lyon, France: IARC Press; 2006:184-188. World Health Organization Classification of Tumours.
6. Mattoch I, Warnke R, Sundram U. Cutaneous peripheral T-cell lymphoma associated with a proliferation of large B-cells ("large B-cell rich T-cell lymphoma") [abstract]. Mod Pathol. 2006;19(suppl 1):85A.
7. Bindl JM, Warnke RA. Advantages of detecting monoclonal antibody binding to tissue sections with biotin and avidin reagents in Coplin jars. Am J Clin Pathol. 1986;85:490-493. (Pubitemid 16052957)
8. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257-2317. (Pubitemid 38072572)
9. Uherova P, Ross CW, Finn WG, et al. Peripheral T-cell lymphoma mimicking marginal zone B-cell lymphoma. Mod Pathol. 2002;15:420-425. (Pubitemid 34326950)
10. Higgins JP, van de Rijn M, Jones CD, et al. Peripheral T-cell lymphoma complicated by a proliferation of large B cells. Am J Clin Pathol. 2000;114:236-247. (Pubitemid 33051872)
11. Förste N, Gellrich S, Golembowski S, et al. Analysis of VH genes rearranged by individual B cells in dermal infiltrates of patients with mycosis fungoides. Clin Exp Immunol. 1997;110:464-471. (Pubitemid 27525280)
12. Golembowski S, Gellrich S, Lorenz P, et al. Mainly unmutated VH genes rearranged in B cells forming germinal centers in a cutaneous pleomorphic T-cell lymphoma. J Cutan Pathol. 1999;26:6-12. (Pubitemid 29041492)
13. Grogg KL, Jung S, Erickson LA, et al. Primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior. Mod Pathol. 2008;21:708-715. (Pubitemid 351744836)
14. Tan SH, Sim CS, Ong BH, et al. Follicular mycosis fungoides mimicking a cutaneous B-cell lymphoproliferative disorder. Australas J Dermatol. 2004;45:188-191. (Pubitemid 39071036)
15. van der Putte SC, Toonstra J, van Wichen DF. B cells and plasma cells in mycosis fungoides: a study including cases with B cell follicle formation or a monotypical plasma cell component. Am J Dermatopathol. 1989;11:509-516. (Pubitemid 20016326)
16. Dunphy CH, Nahass GT. Primary cutaneous T-cell-rich B-cell lymphomas with flow cytometric immunophenotypic findings: report of 3 cases and review of the literature. Arch Pathol Lab Med. 1999;123:1236-1240.
17. Bakels V, van Oostveen JW, van der Putte SC, et al. Immunophenotyping and gene rearrangement analysis provide additional criteria to differentiate between cutaneous T-cell lymphomas and pseudo-T-cell lymphomas. Am J Pathol. 1997;150:1941-1949. (Pubitemid 27233068)
18. Ploysangam T, Breneman DL, Mutasim DF. Cutaneous pseudolymphomas. J Am Acad Dermatol. 1998;38:877-896. (Pubitemid 28299179)
19. Alaibac M, Barbarossa G, Mori M, et al. Polymerase chain reaction analysis of T-cell receptor gamma gene rearrangements in cutaneous B-cell lymphomas. Oncol Rep. 1998;5:409-411. (Pubitemid 28100101)
20. Grogg KL, Attygale AD, Macon WR, et al. Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified. Mod Pathol. 2006;19:1101-1107. (Pubitemid 44106725)
21. Tan BT, Warnke RA, Arber DA. The frequency of B- and T-cell gene rearrangements and Epstein-Barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations. J Mol Diagn. 2006;8:466-475, 527. (Pubitemid 44377929)
22. Ortonne N, Dupuis J, Plonquet A, et al. Characterization of CXCL13+ neoplastic t cells in cutaneous lesions of angioimmunoblastic T-cell lymphoma (AITL). Am J Surg Pathol. 2007;31:1068-1076. (Pubitemid 47012304)
23. Salhany KE, Macon WR, Choi JK, et al. Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes. Am J Surg Pathol. 1998;22:881-893. (Pubitemid 28328234)
24. Krajewski AS, Myskow MW, Salter DM, et al. Diagnosis of T-cell lymphoma using beta F1, anti-T-cell receptor beta chain antibody. Histopathology. 1989;15:239-247. (Pubitemid 19232647)
25. Ng CS, Chan JK, Hui PK, et al. Application of a T cell receptor antibody beta F1 for immunophenotypic analysis of malignant lymphomas. Am J Pathol. 1988;132:365-371. (Pubitemid 18225344)
26. Said JW, Shintaku IP, Parekh K, et al. Specific phenotyping of T-cell proliferations in formalin-fixed paraffin-embedded tissues: use of antibodies to the T-cell receptor beta F1. Am J Clin Pathol. 1990;93:382-386. (Pubitemid 20103065)
27. Hastrup N, Ralfkiaer E, Pallesen G. Aberrant phenotypes in peripheral T cell lymphomas. J Clin Pathol. 1989;42:398-402. (Pubitemid 19121587)
28. Alaibac M, Pigozzi B, Belloni-Fortina A, et al. CD7 expression in reactive and malignant human skin T-lymphocytes. Anticancer Res. 2003;23:2707-2710. (Pubitemid 36897147)
29. Kazakov DV, Kutzner H, Palmedo G, et al. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement. Am J Dermatopathol. 2006;28:399-409. (Pubitemid 44515003)
30. de Bruin PC, Jiwa M, Oudejans JJ, et al. Presence of Epstein-Barr virus in extranodal T-cell lymphomas: differences in relation to site. Blood. 1994;83:1612-1618. (Pubitemid 24081576)
31. Querfeld C, Guitart J, Kuzel TM, et al. Primary cutaneous lymphomas: a review with current treatment options. Blood Rev. 2003;17:131-142. (Pubitemid 36876673)
32. Querfeld C, Rosen ST, Kuzel TM, et al. Cutaneous T-cell lymphomas: a review with emphasis on new treatment approaches. Semin Cutan Med Surg. 2003;22:150-161. (Pubitemid 37392718)